Texas has run out of sotrovimab, a key monoclonal antibody treatment against omicron, due to a national shortage.
The Texas Department of Health and Human Services said the federal government controls the distribution of the monoclonal antibodies and that it expects a new shipment in January.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.